E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/7/2014 in the Prospect News PIPE Daily.

Amedica secures $1 million via 15% bridge loan with Hampshire MedTech

Deal includes warrant for 267,380 common shares, exercisable at $187

By Devika Patel

Knoxville, Tenn., Nov. 7 – Amedica Corp. settled a $1 million bridge loan with Hampshire MedTech Partners II, LP on Nov. 6, according to an 8-K filed Friday with the Securities and Exchange Commission.

The 15% loan is due on Dec. 17, 2014.

Hampshire also received warrants for 267,380 shares, which are each exercisable at $1.87 until Nov. 5, 2019. The strike price reflects an 18.35% premium to the Nov. 5 closing share price of $1.58.

The commercial biomaterial company is based in Salt Lake City.

Issuer:Amedica Corp.
Issue:Bridge loan
Amount:$1 million
Maturity:Dec. 17, 2014
Coupon:15%
Warrants:For 267,380 shares
Warrant expiration:Nov. 5, 2019
Warrant strike price:$1.87
Investor:Hampshire MedTech Partners II, LP
Settlement date:Nov. 6
Stock symbol:Nasdaq: AMDA
Stock price:$1.58 at close Nov. 5
Market capitalization:$17.13 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.